4//SEC Filing
Martin Tami Tillotson 4
Accession 0001104659-24-027564
CIK 0001356576other
Filed
Feb 25, 7:00 PM ET
Accepted
Feb 26, 5:00 PM ET
Size
8.9 KB
Accession
0001104659-24-027564
Insider Transaction Report
Form 4
Martin Tami Tillotson
VP of Regulatory Affairs
Transactions
- Tax Payment
Common Stock
2024-02-22$27.94/sh−246$6,873→ 86,168 total - Disposition to Issuer
Restricted Stock Units
2024-02-22−750→ 1,500 total→ Common Stock (750 underlying) - Award
Common Stock
2024-02-22+750→ 86,414 total
Footnotes (3)
- [F1]Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the RSU vesting.
- [F2]Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.
- [F3]These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 22, 2023.
Documents
Issuer
SUPERNUS PHARMACEUTICALS, INC.
CIK 0001356576
Entity typeother
Related Parties
1- filerCIK 0001539494
Filing Metadata
- Form type
- 4
- Filed
- Feb 25, 7:00 PM ET
- Accepted
- Feb 26, 5:00 PM ET
- Size
- 8.9 KB